Navigating the landscape of end-of-life care and access to medications like this drug in New South Wales, NSW, requires a careful understanding of the detailed legal system. Currently, Pentobarbital does not have a recognized place on the Pharmaceutical Benefits Scheme (the scheme) and is therefore not routinely prescribed by healthcare professiona